Opicapone 25 mg, 50 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 25 mg, 50 mg
Reference Brands: Ongentys (USA/EU)
Category: Neurology
Opicapone is a Neurology product available as Capsules in strengths 25 mg, 50 mg. It corresponds to the reference brand Ongentys (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Opicapone, marketed under the brand name Ongentys, is a peripherally acting catechol-O-methyltransferase (COMT) inhibitor used as adjunctive therapy with levodopa in patients with Parkinson’s disease. It is specifically indicated for individuals experiencing “off” episodes, where the effects of levodopa wear off before the next dose, leading to a return of motor symptoms.
Opicapone works by inhibiting the COMT enzyme in the peripheral tissues, which is responsible for the breakdown of levodopa in the body. By blocking this enzyme outside the brain, opicapone enhances and prolongs the availability of levodopa, allowing more of it to reach the central nervous system where it is converted into dopamine. Importantly, opicapone does not inhibit COMT within the brain, contributing to its targeted peripheral action.
As a result of sustained levodopa levels, dopamine concentrations in brain regions responsible for movement and coordination are better maintained. This leads to improved control of Parkinson’s disease symptoms such as stiffness, slowness of movement, and reduced mobility. With its once-daily dosing and long-lasting COMT inhibition, opicapone provides a convenient and effective option for optimizing levodopa therapy in Parkinson’s disease management.
Opicapone — third party manufacturing & bulk supply
Opicapone 25 mg, 50 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Opicapone listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Opicapone →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Opicapone is used as an add-on treatment to levodopa/carbidopa in adults with Parkinson’s disease who experience end-of-dose “off” periods.
Opicapone is a synthetic small-molecule COMT inhibitor designed to act peripherally without significant central nervous system penetration.
The trade name of opicapone is Ongentys.
Opicapone (Ongentys) is developed and marketed by BIAL – Portela & Cª, S.A.
The generic name of Opicapone is opicapone.
The brand name of Opicapone is Ongentys.
Opicapone is manufactured in EU-based and other GMP-approved global facilities, depending on the market and supply chain.
Related Products
Valproic Acid
Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
View DetailsQuick Response Guaranteed | Verified Suppliers